Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coralien H Vink

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Kidney International Reports|December 19, 2024
Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous NephropathyCoralien H Vink, Jack F M Wetzels, Anne-Els van de Logt
Kidney International|February 22, 2022
Daratumumab for multidrug-resistant phospholipase-A2 receptor-related membranous nephropathyCoralien H Vink, Bram van Cranenbroek, Joost W van der Heijden, et al.
Kidney International|May 5, 2019
The bias between different albumin assays may affect clinical decision-makingAnne-Els van de Logt, Sanna R Rijpma, Coralien H Vink, et al.
Kidney International|June 24, 2019
The authors replyAnne-Els van de Logt, Sanna R Rijpma, Coralien H Vink, et al.
Kidney International Reports|March 20, 2023
Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous NephropathyCoralien H Vink, Anne-Els van de Logt, Renate G van der Molen, et al.
Kidney International Reports|June 25, 2021
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous NephropathyAnne-Els van de Logt, Joana Justino, Coralien H Vink, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Kidney International Reports|December 19, 2024
Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous NephropathyCoralien H Vink, Jack F M Wetzels, Anne-Els van de Logt
Kidney International|February 22, 2022
Daratumumab for multidrug-resistant phospholipase-A2 receptor-related membranous nephropathyCoralien H Vink, Bram van Cranenbroek, Joost W van der Heijden, et al.
Kidney International|May 5, 2019
The bias between different albumin assays may affect clinical decision-makingAnne-Els van de Logt, Sanna R Rijpma, Coralien H Vink, et al.
Kidney International|June 24, 2019
The authors replyAnne-Els van de Logt, Sanna R Rijpma, Coralien H Vink, et al.
Kidney International Reports|March 20, 2023
Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous NephropathyCoralien H Vink, Anne-Els van de Logt, Renate G van der Molen, et al.
Kidney International Reports|June 25, 2021
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous NephropathyAnne-Els van de Logt, Joana Justino, Coralien H Vink, et al.
Pageof 1